Use of Clinical Practice Guidelines on Long-term Prophylaxis in Severe Hemophilia in France: A Retrospective Audit - 23/05/13
Reprint requests: Marc Trossaërt, MD, PhD, Centre Régional de Traitement de l’Hémophilie, 1 Place Alexis Ricordeau, CHU Hôtel-Dieu, 44093 Nantes Cedex 1, France.Abstract |
Objectives |
To evaluate the impact of the 2002 guidelines on the current status of prophylaxis in French children with severe hemophilia A or B.
Study design |
Clinical information was captured, in a prospective way, using FranceCoag Network. We retrospectively studied 291 patients with severe (<1 IU/dL) hemophilia A and B, with no history of inhibitors.
Results |
Our results demonstrate that the availability of national medical guidelines has improved clinical practice in France. In the past decade, the proportion of children with severe hemophilia undergoing prophylaxis has shown a significant 2- to 3-fold increase: 
80% of these children >3 years of age are now receiving prophylaxis. In severe hemophilia A and B, the age at which prophylaxis commences has significantly decreased: 4.0 and 6.1 years for the period 1996-1999 as opposed to 1.8 and 1.4 years for the period 2004-2007 (P = .0001).
Conclusions |
Long-term clinical and physical evaluations of patients will be necessary to establish the benefits of this increase in prophylactic treatment on the prevention of hemophilic arthropathy.
Le texte complet de cet article est disponible en PDF.Keyword : CoMETH
Plan
| The authors declare no conflicts of interest. |
Vol 162 - N° 6
P. 1241 - juin 2013 Retour au numéro
Article précédent
- Endocrine Evaluation of Children with and without Shwachman-Bodian-Diamond Syndrome Gene Mutations and Shwachman-Diamond Syndrome
- Kasiani C. Myers, Susan R. Rose, Meilan M. Rutter, Parinda A. Mehta, Jane C. Khoury, Theresa Cole, Richard E. Harris
- Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis
- Kai Lehmberg, Isabell Pink, Christine Eulenburg, Karin Beutel, Andrea Maul-Pavicic, Gritta Janka
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?